We are live on ! Find out more
WSC

Wellington Shields & Co Portfolio holdings

AUM $392M
1-Year Est. Return 30.65%
This Fund
S&P 500
This Quarter Est. Return
+24.75%
1 Year Est. Return
+30.65%
3 Year Est. Return
+75.6%
5 Year Est. Return
+100.7%
10 Year Est. Return
+459.98%
AUM
$279M
AUM Growth
+$41.2M
Cap. Flow
-$4.04M
Cap. Flow %
-1.45%
Top 10 Hldgs %
43.17%
Holding
198
New
18
Increased
45
Reduced
61
Closed
9

Top Buys

Rank Stock Value
1
FIRY
Firy Inc
FIRY
+$4.25M
2
RPRX icon
Royalty Pharma
RPRX
+$4.02M
3
CASI
CASI Pharmaceuticals
CASI
+$724K
4
WMT icon
Walmart Inc
WMT
+$510K
5
UL icon
Unilever
UL
+$314K

Top Sells

Rank Stock Value
1
CTEV
Claritev Corp
CTEV
+$4.05M
2
COHR icon
Coherent
COHR
+$2.64M
3
DKNG icon
DraftKings
DKNG
+$1.93M
4
ILMN icon
Illumina
ILMN
+$1.26M
5
STZ icon
Constellation Brands
STZ
+$730K

Sector Composition

Rank Sector Weight
1 Healthcare 33.89%
2 Technology 19.34%
3 Industrials 10.76%
4 Financials 9.29%
5 Communication Services 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSNL icon
1
Personalis
PSNL
$1.33B
$33.7M 12.07%
920,478
-11,000
-1% -$333K
ILMN icon
2
Illumina
ILMN
$29.5B
$22.9M 8.2%
63,638
-3,958
-6% -$1.26M
MSFT icon
3
Microsoft
MSFT
$2.85T
$19M 6.8%
85,394
-483
-0.6% -$104K
AAPL icon
4
Apple
AAPL
$4.89T
$11.9M 4.26%
89,717
-690
-0.8% -$83K
BE icon
5
Bloom Energy
BE
$57.8B
$6.2M 2.22%
216,312
-15,260
-7% -$326K
JPM icon
6
JPMorgan Chase
JPM
$938B
$5.85M 2.09%
46,008
-520
-1% -$58.1K
FIRY
7
Firy Inc
FIRY
$128M
$5.72M 2.05%
+14,310
New +$4.25M
CASI
8
DELISTED
CASI Pharmaceuticals
CASI
$5.35M 1.92%
181,277
+33,315
+23% +$724K
DIS icon
9
Walt Disney
DIS
$166B
$5.02M 1.8%
27,728
-145
-0.5% -$20.8K
SHOP icon
10
Shopify
SHOP
$146B
$4.87M 1.74%
43,000
-4,000
-9% -$420K
RPRX icon
11
Royalty Pharma
RPRX
$26.1B
$4.74M 1.7%
+94,670
New +$4.02M
HON icon
12
Honeywell
HON
$77B
$4.64M 1.66%
23,139
+848
+4% +$154K
AMZN icon
13
Amazon
AMZN
$2.51T
$4.17M 1.49%
25,600
+1,120
+5% +$179K
UNP icon
14
Union Pacific
UNP
$183B
$3.79M 1.36%
18,220
IBM icon
15
IBM
IBM
$202B
$3.53M 1.26%
29,309
-5,985
-17% -$692K
CVS icon
16
CVS Health
CVS
$137B
$3.26M 1.17%
47,743
-2,340
-5% -$152K
ABBV icon
17
AbbVie
ABBV
$458B
$3.21M 1.15%
29,991
-321
-1% -$30.8K
BMY icon
18
Bristol-Myers Squibb
BMY
$127B
$3.19M 1.14%
51,415
-700
-1% -$43K
T icon
19
AT&T
T
$163B
$3.17M 1.14%
146,146
+738
+0.5% +$15.9K
VZ icon
20
Verizon
VZ
$189B
$3.11M 1.11%
52,910
+567
+1% +$33.7K
LLY icon
21
Eli Lilly
LLY
$1.07T
$2.95M 1.06%
17,473
-85
-0.5% -$12.7K
SPGI icon
22
S&P Global
SPGI
$125B
$2.93M 1.05%
8,900
PFE icon
23
Pfizer
PFE
$140B
$2.75M 0.99%
74,857
-4,948
-6% -$181K
ABT icon
24
Abbott
ABT
$181B
$2.69M 0.96%
24,569
+26
+0.1% +$2.83K
JNJ icon
25
Johnson & Johnson
JNJ
$633B
$2.4M 0.86%
15,258
+13
+0.1% +$1.92K

Similar funds

Wellington Shields & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Wellington Shields & Co held 198 positions worth $279M, up 17% from $238M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Wellington Shields & Co's Q4 2020 filing shows 18 new, 45 increased, 61 reduced and 9 closed positions. Its largest new stake was Firy Inc: 14,310 shares worth $5.72M. The largest sale was Claritev Corp, an estimated $4.05M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.

  • Wellington Shields & Co's largest Q4 2020 buy was Firy Inc: 14,310 shares worth $5.72M.
  • Wellington Shields & Co added most to CASI Pharmaceuticals in Q4 2020, an estimated $724K increase.
  • Wellington Shields & Co's biggest Q4 2020 reduction was DraftKings, cutting an estimated $1.93M.
  • Wellington Shields & Co fully exited Claritev Corp in Q4 2020, selling an estimated $4.05M.
  • Wellington Shields & Co's ten largest holdings make up 43% of its $279M portfolio in Q4 2020.
  • Wellington Shields & Co opened 18 new positions and closed 9 in Q4 2020.
  • Wellington Shields & Co's portfolio value rose 17% quarter-over-quarter to $279M.

Based on Wellington Shields & Co's 13F filing for Q4 2020, filed 9 Feb 2021.